Phenothiazine
Drug profile
Also known as: NSC-2037
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Phenothiazine is a drug catalogued in DrugCentral. DrugCentral lists 16 molecular targets, including Sigmar1, CYP1A2 and PTGS1.
- Molecular targets: Sigmar1, CYP1A2, PTGS1 and SLC6A2 (16 listed in DrugCentral).
- Molecular formula: C12H9NS; molecular weight 199.27 g/mol.
Mechanism & targets
Molecular targets (16)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Sigma non-opioid intracellular receptor 1 | Sigmar1 | unknown | Ki 8.37 |
| Cytochrome P450 1A2 | CYP1A2 | unknown | IC50 7.80 |
| Prostaglandin G/H synthase 1 | PTGS1 | unknown | IC50 6.71 |
| Sodium-dependent noradrenaline transporter | SLC6A2 | unknown | IC50 6.34 |
| Prostaglandin G/H synthase 2 | PTGS2 | unknown | IC50 6.27 |
| Amine oxidase [flavin-containing] A | MAOA | unknown | IC50 6.23 |
| 5-hydroxytryptamine receptor 2C | HTR2C | unknown | Ki 5.93 |
| Arachidonate 5-lipoxygenase | Alox5 | unknown | IC50 5.85 |
| Sigma intracellular receptor 2 | Tmem97 | unknown | Ki 5.83 |
| Arachidonate 15-lipoxygenase | ALOX15 | unknown | IC50 5.33 |
| Cholinesterase | BCHE | unknown | IC50 5.24 |
| Acetylcholinesterase | ACHE | unknown | IC50 5.14 |
| Adenosine receptor A3 | ADORA3 | unknown | Ki 4.84 |
| Sodium-dependent dopamine transporter | SLC6A3 | unknown | Ki 4.83 |
| Cannabinoid receptor 1 | CNR1 | unknown | Ki 4.71 |
| Alpha-synuclein | SNCA | unknown | IC50 4.58 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| — | FDA | — | — |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Completed suicide | 147.9 |
| Toxicity to various agents | 68.9 |
| Cardio-respiratory arrest | 57.6 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Phenothiazine is on its molecule page.
| Molecular formula | C12H9NS |
|---|---|
| Molecular weight | 199.27 g/mol |
| CAS number | 92-84-2 |
| InChIKey | WJFKNYWRSNBZNX-UHFFFAOYSA-N |
| PubChem CID | 7108 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Phenothiazine work?
Its molecular targets in DrugCentral include Sigmar1, CYP1A2, PTGS1 and SLC6A2.
What is the chemical formula of Phenothiazine?
Phenothiazine has the molecular formula C12H9NS and a molecular weight of 199.27 g/mol.
Browse: all drugs starting with P · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 5597 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL828 — compound record and bioactivity
- PubChem CID 7108 — chemical identifiers
- DrugBank DB11447 — drug record
- FDA UNII GS9EX7QNU6 — substance identity
- DailyMed: FDA labels for Phenothiazine — current prescribing information (label search)
- UniProt P05177 (CYP1A2) — target protein
- UniProt P23219 (PTGS1) — target protein
- UniProt P23975 (SLC6A2) — target protein
- UniProt P35354 (PTGS2) — target protein
- UniProt P21397 (MAOA) — target protein
- UniProt P28335 (HTR2C) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.